Continuing anti-tumor necrosis factor (anti-TNF) therapy after 24 weeks of pregnancy is associated with a lower likelihood of relapse of inflammatory bowel disease (IBD) in pregnant women and fewer ...
In pregnant women with sickle cell disease, the risk of developing early-onset preeclampsia can be determined by measuring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback